Pharma Marketing Network

JUNE 5, 2025

In 2025, the pharmaceutical industry is undergoing a digital revolution, and programmatic advertising is at the heart of it. In 2025, the use of artificial intelligence and machine learning has significantly advanced audience segmentation. For HCP campaigns, dynamic creative optimization (DCO) is widely used.

HIPAA 52

HIPAA Hospitals FDA 52

Pharma Marketing Network

JANUARY 7, 2025

In 2025, pharma marketing news is filled with innovation, disruption, and opportunities to grow your business. In 2025, digital channels dominate marketing strategies as companies shift from traditional campaigns to online platforms. Lets dive into the trends shaping the industry and how you can use them to craft winning strategies.

HIPAA 52

HIPAA Pharmaceutical Companies Pharmaceutical Companies FDA 52

Pharma Marketing Network

APRIL 10, 2025

It means using data responsibly to tailor content, recommend resources, and support adherenceall while complying with HIPAA and other healthcare regulations. Ad copy and landing pages must include ISI (Important Safety Information), follow FDA and PhRMA guidelines, and offer fair balance when promoting branded products.

HIPAA 52

HIPAA Communication FDA 52

Pharma Marketing Network

MAY 9, 2025

Healthcare advertising in 2025 must be: Contextual: Ads should meet the user at the right moment with the right message. Compliant: Campaigns must align with HIPAA, GDPR, and FDA guidelines. Trust Signals: Include third-party logos, medical references, or FDA-clearance language where permitted.

HIPAA 52

HIPAA FDA Communication 52

Pharma Marketing Network

MAY 22, 2025

But in 2025, the AI is Changing Pharma Marketing. In 2025, brand managers who cant interpret or apply AI-driven insights risk falling behind. Is AI in pharma marketing compliant with FDA regulations? Brands must use pre-approved content, document decision-making, and ensure HIPAA-compliant targeting practices.

HIPAA 52

HIPAA Documentation FDA 52

Pharma Marketing Network

APRIL 3, 2025

This article dives deep into how patient marketing has changed, whats driving this transformation, and what strategies are leading the way for 2025 and beyond. These tools help pharma brands deliver HIPAA-compliant, personalized content to segmented audiences based on health behavior and condition.

HIPAA 52

HIPAA Communication Packaging Pharmaceutical Companies 52

Pharma Marketing Network

MARCH 20, 2025

This guide explores essential strategies to ensure your team is prepared for the shifting dynamics of healthcare marketing in 2025 and beyond. Regulatory frameworks such as HIPAA, GDPR, and FDA guidelines dictate how pharmaceutical brands can advertise and engage with healthcare professionals (HCPs) and patients.

HIPAA 52

HIPAA FDA 52

ISPE

OCTOBER 27, 2022

Given the public health emergency, health authorities offered greater flexibilities in the use of digital health platforms and technologies such as: Enhanced HIPAA (Health Insurance Portability and Accountability Act of 1996) flexibilities in the use of telemedicine services 3.

Health and Personal Care Stores 52

Health and Personal Care Stores FDA HIPAA Communication 52

ISPE

OCTOBER 27, 2022

In December 2021, the US FDA issued a cross-center draft guidance with recommendations on the use of digital health technology tools (DHTTs) to acquire data remotely from participants in clinical investigations for medical products. Table 3: Example classification of DHTs. .

Health and Personal Care Stores 52

Health and Personal Care Stores FDA Communication Clinic Management 52

The FDA Law Blog

MAY 26, 2025

The political battle went into gear on January 28, 2025, with an Executive Order titled Protecting Children from Chemical and Surgical Mutilation. The EO and DOJ memo were followed by a May 1, 2025 announcement of a report from the U.S. The gray box at the top of the document at this link shows the change in position.

Labelling 59

Labelling HIPAA Documentation FDA 59